Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers

Wanying Li, Ziyang Wang, Xiaoliang Chen, Yong Qin, Dong Dai

Open source

DOI
10.3389/fonc.2026.1812790
Published
2026-03-16
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1812790,
  title = {Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers},
  author = {Wanying Li and Ziyang Wang and Xiaoliang Chen and Yong Qin and Dong Dai},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1812790},
  url = {https://doi.org/10.3389/fonc.2026.1812790}
}

RIS

TY  - JOUR
TI  - Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers
AU  - Wanying Li
AU  - Ziyang Wang
AU  - Xiaoliang Chen
AU  - Yong Qin
AU  - Dong Dai
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1812790
UR  - https://doi.org/10.3389/fonc.2026.1812790
ER  - 

APA

Li, W., Wang, Z., Chen, X., Qin, Y., & Dai, D. (2026). Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1812790

Source records